HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ross G Bentley Selected Research

SB 234551

7/2008SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ross G Bentley Research Topics

Disease

2Stroke (Strokes)
09/2009 - 07/2008
1Dyslipidemias (Dyslipidemia)
09/2009
1Cardiovascular Diseases (Cardiovascular Disease)
09/2009
1Hypertension (High Blood Pressure)
09/2009
1Cardiomegaly (Heart Hypertrophy)
09/2009
1Brain Injuries (Brain Injury)
07/2008
1Infarction (Infarctions)
07/2008
1Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
07/2008

Drug/Important Bio-Agent (IBA)

1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
09/2009
1Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
09/2009
1Interleukin-1beta (Interleukin 1 beta)IBA
09/2009
1Anti-Inflammatory Agents (Anti-Inflammatories)IBA
09/2009
1rofecoxib (Vioxx)FDA Link
09/2009
1p38 Mitogen-Activated Protein KinasesIBA
09/2009
16- (5- ((cyclopropylamino)carbonyl)- 3- fluoro- 2- methylphenyl)- N- (2,2- dimethylprpyl)- 3- pyridinecarboxamideIBA
09/2009
1Niacinamide (Nicotinamide)FDA LinkGeneric
09/2009
1ReninIBA
09/2009
1SaltsIBA
09/2009
1AldosteroneIBA
09/2009
1SB 234551IBA
07/2008
1salicylhydroxamic acid (SHAM)IBA
07/2008

Therapy/Procedure

1Time-to-Treatment
07/2008